Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 739-745

  Xiao, Fei ^a   Chen, Juwu ^a   Lian, Chuanju ^a   Han, Pengchao ^a   Zhang, Chaoyang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adenovirus; MicroRNA 122; MicroRNA 34; Osteosarcoma; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ADENOVIRUS VECTOR; MICRORNA; MICRORNA 122; MICRORNA 34; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER TOXICITY; LUCIFERASE ASSAY; MOUSE; MTT ASSAY; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADENOVIRIDAE; ANIMAL; BONE TUMOR; CELL SURVIVAL; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MICRORNAS; OSTEOSARCOMA; RESPONSE ELEMENTS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84916241674     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2710     Document Type: Article

References (17)

1. Ando K, Heymann MF, Stresing V, Mori K, Redini F and Heymann D: Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel) 5: 591-616, 2013.
2. Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
3. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999.
4. Muzio M, Chinnaiyan AM, Kischkel FC, et al: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.
5. Li C, Cheng Q, Liu J, Wang B, Chen D and Liu Y: Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma. Mol Cell Biochem 364: 337-344, 2012.
6. Wu J, Zeng T, Wu X, Gao Q, Zhai W and Ding Z: Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma. Cancer Biother Radiopharm 28: 65-70, 2012.
7. Mitsiades N, Poulaki V, Mitsiades C and Tsokos M: Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Cancer Res 61: 2704-2712, 2001.
8. Zheng SJ, Wang P, Tsabary G and Chen YH: Critical roles of TRAIL in hepatic cell death and hepatic infammation. J Clin Invest 113: 58-64, 2004.
9. Miao J, Wu S, Peng Z, Tania M and Zhang C: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol 34: 2093-2098, 2013.
10. He C, Xiong J, Xu X, et al: Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun 388: 35-40, 2009.
11. Ma L, Liu J, Shen J, et al: Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther 9: 554-561, 2010.
12. Liu J, Ma L, Li C, Zhang Z, Yang G and Zhang W: Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol 7: 1043-1055, 2013.
13. Bo Y, Guo G and Yao W: MiRNA-mediated tumor specifc delivery of TRAIL reduced glioma growth. J Neurooncol 112: 27-37, 2013.
14. Zhao Y, Li Y, Wang L, et al: microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer. J Exp Clin Cancer Res 32: 10, 2013.
15. Wang B, Liu J, Ma LN, et al: Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling. J Gastroenterol 48: 798-808, 2013.
16. Lou W, Chen Q, Ma L, et al: Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. J Mol Med (Berl) 91: 715-725, 2013.
17. He X, Liu J, Yang C, et al: 5/35 fber-modifed conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. Hum Gene Ther 22: 283-292, 2011.